(IN BRIEF) A new spin-out drug discovery company from the University of Liverpool called Sulantrix is exploring new cancer medicines targeting previously untapped classes of pseudoenzymes. The company is led by Professor Patrick Eyers and CEO David Williams, who has … Read the full press release
Posted in Education, Healthcare, Pharma & Biotech, Science, Technology, United Kingdom
Tagged AI, Cancer, David Williams, Dr Emma Fairweather, drug discovery, Emma Nolan, Enterprise Investment Funding, ISMIB, Multi-omics Platforms, Professor Anthony Hollander, Professor Patrick Eyers, pseudoenzymes, spin-out, Sulantrix, University of Liverpool
LIVERPOOL, 24-Jul-2017 — /EuropaWire/ — The University has announced three new appointments to its senior leadership team. Professor Louise Kenny has been appointed to the role of Executive Pro-Vice-Chancellor for the Faculty of Health and Life Sciences. An alumna of the University’s School of … Read the full press release
LIVERPOOL, 22-Jul-2016 — /EuropaWire/ — Professor Anthony Hollander, from the University of Liverpool’s Institute of Integrative Biology, has presented evidence to the House of Commons Science and Technology Committee on Regenerative Medicine. Professor Hollander is a leading expert in stem cell biology … Read the full press release
A company, founded by University of Liverpool scientist, Professor Anthony Hollander, has been awarded £2 million to develop stem cell technologies that have shown potential in repairing damaged tissue in the knee. LIVERPOOL, 18-5-2015 — /EuropaWire/ — The team at … Read the full press release
Posted in Education, Financial, Healthcare, Science, Technology, United Kingdom
Tagged Azellon, Innovate UK and Cell Therapy Catapult, meniscal cartilage, NHS Blood and Transplant, Professor Anthony Hollander, stem cell technologies, treatment of damaged fibrous tissues in the knee, University of Liverpool
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?
PHARMA & BIOTECH: The largest repository of EU/European pharma & biotech press releases spanning 12 years (2012-2024)
